Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00116753

Public ClinicalTrials.gov record NCT00116753. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 1:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Multi-center, Randomized Parallel Group Comparison of Efficacy and Safety of Degarelix Three-Month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The rationale of the study was to evaluate different degarelix dosing regimens for a three-month interval that was to produce and maintain castration in prostate cancer patients through immediate and prolonged testosterone suppression, and to provide confirmatory evidence of the safety of degarelix.

Study identification

NCT ID
NCT00116753
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
460 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2005 (Type not available)
Primary completion
Nov 2006 (Actual)
Completion
Nov 2006 (Actual)
Last update posted
Dec 10, 2010

2005 – 2006

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Urology Centers of Alabama Homewood Alabama 35209 —
Medical Affiliationed Research Center Huntsville Alabama 35801 —
Alaska Clinical Research Center, LLC Anchorage Alaska 99508 —
Advanced Urology Medical Center Anaheim California 92801 —
Center for Urological Research La Mesa California 91942 —
South Orange County Medical Research Center Laguna Woods California 92653 —
West Coast Clinical Research Tarzana California 91356 —
Western Clinical Research Torrance California 90505 —
Urology Research Option Aurora Colorado 80012 —
South Florida Medical Research Aventura Florida 33180 —
RT Services, Inc Fort Myers Florida 33901 —
SW Florida Urological Associates Fort Myers Florida 33907 —
Regional Urology Shreveport Louisiana 71106 —
Mississippi Urology Clinic Jackson Mississippi 39202 —
University of Missouri, Urology, Deptof Surgery Columbia Missouri 65212 —
Kansas City Urology Care Kansas City Missouri 64131 —
Northeast Urology Research Concord North Carolina 28025 —
The Urology Center Greensboro North Carolina 27401 —
State College Urologic Association State College Pennsylvania 16801 —
Grand Strand Urology Myrtle Beach South Carolina 29572 —
Urology Association of Northern Texas Fort Worth Texas 76104 —
Urology San Antonio Research San Antonio Texas 78229 —
Seatle Urology Research Centre Seattle Washington 98166 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00116753, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2010 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00116753 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →